Jennison Associates LLC Acquires 321,759 Shares of Intuitive Surgical, Inc. $ISRG

Jennison Associates LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 3,209,137 shares of the medical equipment provider’s stock after purchasing an additional 321,759 shares during the period. Intuitive Surgical accounts for 1.1% of Jennison Associates LLC’s investment portfolio, making the stock its 28th largest holding. Jennison Associates LLC’s holdings in Intuitive Surgical were worth $1,817,527,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Newbridge Financial Services Group Inc. lifted its stake in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares in the last quarter. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $25,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Turning Point Benefit Group Inc. lifted its stake in Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Finally, Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $27,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Sanford C. Bernstein increased their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. The Goldman Sachs Group raised their price objective on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research report on Wednesday, April 22nd. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Raymond James Financial lowered their price objective on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Finally, HSBC lowered their price objective on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $581.91.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Erste Group raised its EPS forecasts (FY2026 to $8.56 and FY2027 to $9.83), signaling rising analyst confidence in Intuitive’s profitability outlook — this supports longer-term upside versus consensus.
• Positive Sentiment: Strong Q1 results and completed buyback — Intuitive reported better-than-expected Q1 revenue and EPS and finished a multi-year $9.08B repurchase (29.44M shares), boosting EPS via a smaller share count and demonstrating shareholder-return focus. How Strong Q1 2026 Results and Completed Buyback Will Impact Intuitive Surgical (ISRG) Investors
• Neutral Sentiment: Director Amy L. Ladd sold shares under a pre-arranged Rule 10b5-1 plan (transactions at ~$463–$473); scheduled plan sales limit the informational value of the trades but can add short-term supply. SEC Filing — Insider Sale
• Neutral Sentiment: International mix: analysts note stronger overall OUS growth but some pressure in China and delays in Japan that could temper international upside relative to the U.S. momentum. Is ISRG’s International Weakness a Temporary Drag or Structural Risk?
• Negative Sentiment: FDA early alert about removal of certain 8mm SureForm 30 gray reloads (curved-tip staplers) re-focused investor attention on product-safety/regulatory risk; that notice, combined with profit-taking after a post-earnings rally, is the proximate cause of today’s pullback. Intuitive Surgical slips as investors weigh recent FDA stapler notice and post-earnings expectations
• Negative Sentiment: Valuation sensitivity after the strong post-earnings rally — some investors and at least one bank have trimmed price targets or tempered projections, making the stock vulnerable to short-term profit-taking despite solid fundamentals.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 5,906 shares of company stock worth $2,907,726 over the last 90 days. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $451.17 on Thursday. The firm’s fifty day moving average price is $475.70 and its 200-day moving average price is $516.39. The stock has a market cap of $159.79 billion, a P/E ratio of 54.67, a price-to-earnings-growth ratio of 3.79 and a beta of 1.68. Intuitive Surgical, Inc. has a fifty-two week low of $427.84 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter last year, the company posted $1.81 EPS. On average, analysts predict that Intuitive Surgical, Inc. will post 8.5 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.